To provide a novel immunotherapeutic agent which can be used for treatment of gastric cancer and the like including diffuse-type gastric carcinoma. An antibody that binds to sulfated glycosaminoglycan and has cell growth inhibitory activity is provided. The antibody of the present invention can be used as a cell growth inhibitor, a targeting reagent for drug delivery, or an agent for detecting cancer.
